- Home
- Industry Reports
- Healthcare
- Pharmaceuticals
- Global Anesthesia Drug Market – Share, Outlook, Trends, Size and Forecast (2024 – 2032)
The market has been estimated at USD 11.58 billion in 2018 and is projected to reach USD 14.16 billion by 2024, at a CAGR of 3.7% during the forecast period from 2018 to 2024. Anesthesia is defined as a temporary state of unconsciousness, lack of pain, loss of memory and muscle relaxation. Generally, the word medically means, placed in an unconscious state for surgery. While the word anesthesia may be a relief to some who want to avoid the pain of surgery, the risks associated with medically induced unconsciousness can create fear in others.
Global Anesthesia Drugs Market Share:
In Global Anesthesia Drugs Market, general anesthesia drugs segment accounted for the maximum market share during 2018 and will continue to dominate the market for the next four years. It has been estimated that the market will further benefit from the rising incidences of chronic respiratory diseases, cardiovascular diseases, craniomaxillofacial surgeries, and accidents along with the rapid adoption of propofol.
Global Anesthesia Drugs Market Size:
North America and Europe Anesthesia Drugs Market dominated the overall Anesthesia Drugs Market in 2018 and is expected to hold its position over the forecast period 2018-2014. The presence of various clinical research labs in North America and Europe working towards the introduction of new anesthesia drugs are also boosting the anesthesia drug market.
Global Anesthesia Drugs Market Growth:
Increasing number of surgeries, development of new sedative & anesthetic drugs, reduction in the cost of newly invented medications and a decrease in the recovery time after surgery are some of the factors driving the growth of the Anesthesia Drug market.
Global Anesthesia Drugs Market Industry Analysis:
The Global Anesthesia Drug market can be broadly segmented into Type and Routes of Administration. The market is segmented further by type as general anesthesia, spinal anesthesia, IV regional anesthesia, interscalene block, local anesthesia, peripheral nerve block, saddle block anesthesia. Inhalation and injection are the two forms of routes of administration.
Global Anesthesia Drugs Market Outlook:
The growing volume of surgical procedures will drive the growth prospects for the worldwide anesthesia drugs market in future. Analysts predict that the increasing demand for anesthesia in labor is driving the market growth. According to the Centers for Disease Control and Prevention (CDC), the total number of deliveries including vaginal and caesarean are 3,984,502 in the US.
Global Anesthesia Drugs Market Trends:
Baxter International Inc has been recognized as a Military Friendly Employer for 2018 by Victory Media. Baxter champions veterans’ initiatives through networking, community outreach, military advocacy, recruiting and mentoring. Abbott Industry wins Chicago Innovation Award for a pioneering breakthrough in infant formula.
Global Anesthesia Drugs Market Research report includes:
- An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
- To have complete market analysis through industry value chain analysis, Porter’s five, PESTLE, SWOT analysis, and Y-o-Y analysis.
- Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year–On–Year
- Identifying DROC in the current market and their impact in altering the market dynamics.
- Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.
- Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
- Identify the latest developments, market shares and strategies that are employed by the major market players, such as
- Abbott
- Baxter
- Braun
- Aspen
- Roche
Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter’s Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threat
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
Chapter 5 Market Segmentation Analysis
Chapter 6 Market Segmentation, By Type
6.1 Saddle Block Anesthesia
6.2 Peripheral Nerve Block
6.3 Local Anesthesia
6.4 IV Regional Anesthesia
6.5 Interscalene block
6.6 Spinal Anesthesia
6.7 General Anesthesia
Chapter 7 Market Segmentation, By Routes of Administration
7.1 Injection
7.2 Inhalation
Chapter 8 Market Segmentation, By Geography
8.1 North America
8.1.1 Introduction
8.1.2 United States
8.1.3 Canada
8.1.4 Mexico
8.1.5 Others
8.2 Europe
8.2.1 Introduction
8.2.2 U.K
8.2.3 Spain
8.2.4 Italy
8.2.5 France
8.2.6 Russia
8.2.7 Others
8.3 Asia-Pacific
8.3.1 Introduction
8.3.2 China
8.3.3 India
8.3.4 Japan
8.3.5 Australia
8.3.6 Others
8.4 South America
8.4.1 Introduction
8.4.2 Brazil
8.4.3 Argentina
8.4.4 Others
8.5 The Middle East & Africa
8.5.1 Introduction
8.5.2 South Africa
8.5.3 Others
Chapter 9 Competitive Landscape
9.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements
9.2 Market Share Analysis
9.3 Strategies Adopted By Top Companies
Chapter 10 Company Profiles
10.1. Boehringer Ingelheim
10.1.1. Company Overview
10.1.2. Financial Performance
10.1.3. Product Benchmarking
10.1.4. Strategic Initiative
10.2. Pfizer
10.3. Novartis
10.4. Roche
10.5. AstraZeneca
10.6. Piramal
10.7. Abbott
10.8. Hospira
10.9. Baxter
10.10. AbbVie
10.11. Aspen
10.12. B. Braun
10.13. Fresenius Kabi
10.14. Hikma Pharmaceuticals PLC
10.15. Mylan N.V.
Chapter 11 Market Estimates and Forecast
11.1 Market Estimates and Forecast 2018-2024(USD Million)
11.1.1 Market Estimation and Forecast by Type 2018-2024 (USD Million)
11.1.2 Market Estimation and Forecast by Routes of Administration 2018-2024 (USD Million)
11.1.3 Market Estimates and Forecast by Geography 2018-2024 (USD Million)
Chapter 12 Market Insights
12.1 Insights of Industry Experts
12.2 Analyst Opinion (Market Understanding)
12.3 Investment Opportunities
Chapter 13 Appendix
13.1 List of Tables
13.2 List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Global Report
$2,700.00 – $8,100.00
- EUR: €2,489.86 - €7,469.57
- INR: ₹225,053.86 - ₹675,161.59
- AED: د.إ9,909.00 - د.إ29,727.00
- GBP: £2,133.43 - £6,400.30
Additional information
Report Type | Extensive Report, Miniature report, Snapshot Report |
---|---|
Licence | Single User License, Team License, Corporate License |
The market has been estimated at USD 11.58 billion in 2018 and is projected to reach USD 14.16 billion by 2024, at a CAGR of 3.7% during the forecast period from 2018 to 2024. Anesthesia is defined as a temporary state of unconsciousness, lack of pain, loss of memory and muscle relaxation. Generally, the word medically means, placed in an unconscious state for surgery. While the word anesthesia may be a relief to some who want to avoid the pain of surgery, the risks associated with medically induced unconsciousness can create fear in others.
Global Anesthesia Drugs Market Share:
In Global Anesthesia Drugs Market, general anesthesia drugs segment accounted for the maximum market share during 2018 and will continue to dominate the market for the next four years. It has been estimated that the market will further benefit from the rising incidences of chronic respiratory diseases, cardiovascular diseases, craniomaxillofacial surgeries, and accidents along with the rapid adoption of propofol.
Global Anesthesia Drugs Market Size:
North America and Europe Anesthesia Drugs Market dominated the overall Anesthesia Drugs Market in 2018 and is expected to hold its position over the forecast period 2018-2014. The presence of various clinical research labs in North America and Europe working towards the introduction of new anesthesia drugs are also boosting the anesthesia drug market.
Global Anesthesia Drugs Market Growth:
Increasing number of surgeries, development of new sedative & anesthetic drugs, reduction in the cost of newly invented medications and a decrease in the recovery time after surgery are some of the factors driving the growth of the Anesthesia Drug market.
Global Anesthesia Drugs Market Industry Analysis:
The Global Anesthesia Drug market can be broadly segmented into Type and Routes of Administration. The market is segmented further by type as general anesthesia, spinal anesthesia, IV regional anesthesia, interscalene block, local anesthesia, peripheral nerve block, saddle block anesthesia. Inhalation and injection are the two forms of routes of administration.
Global Anesthesia Drugs Market Outlook:
The growing volume of surgical procedures will drive the growth prospects for the worldwide anesthesia drugs market in future. Analysts predict that the increasing demand for anesthesia in labor is driving the market growth. According to the Centers for Disease Control and Prevention (CDC), the total number of deliveries including vaginal and caesarean are 3,984,502 in the US.
Global Anesthesia Drugs Market Trends:
Baxter International Inc has been recognized as a Military Friendly Employer for 2018 by Victory Media. Baxter champions veterans’ initiatives through networking, community outreach, military advocacy, recruiting and mentoring. Abbott Industry wins Chicago Innovation Award for a pioneering breakthrough in infant formula.
Global Anesthesia Drugs Market Research report includes:
- An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
- To have complete market analysis through industry value chain analysis, Porter’s five, PESTLE, SWOT analysis, and Y-o-Y analysis.
- Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year–On–Year
- Identifying DROC in the current market and their impact in altering the market dynamics.
- Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.
- Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
- Identify the latest developments, market shares and strategies that are employed by the major market players, such as
- Abbott
- Baxter
- Braun
- Aspen
- Roche
Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter’s Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threat
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
Chapter 5 Market Segmentation Analysis
Chapter 6 Market Segmentation, By Type
6.1 Saddle Block Anesthesia
6.2 Peripheral Nerve Block
6.3 Local Anesthesia
6.4 IV Regional Anesthesia
6.5 Interscalene block
6.6 Spinal Anesthesia
6.7 General Anesthesia
Chapter 7 Market Segmentation, By Routes of Administration
7.1 Injection
7.2 Inhalation
Chapter 8 Market Segmentation, By Geography
8.1 North America
8.1.1 Introduction
8.1.2 United States
8.1.3 Canada
8.1.4 Mexico
8.1.5 Others
8.2 Europe
8.2.1 Introduction
8.2.2 U.K
8.2.3 Spain
8.2.4 Italy
8.2.5 France
8.2.6 Russia
8.2.7 Others
8.3 Asia-Pacific
8.3.1 Introduction
8.3.2 China
8.3.3 India
8.3.4 Japan
8.3.5 Australia
8.3.6 Others
8.4 South America
8.4.1 Introduction
8.4.2 Brazil
8.4.3 Argentina
8.4.4 Others
8.5 The Middle East & Africa
8.5.1 Introduction
8.5.2 South Africa
8.5.3 Others
Chapter 9 Competitive Landscape
9.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements
9.2 Market Share Analysis
9.3 Strategies Adopted By Top Companies
Chapter 10 Company Profiles
10.1. Boehringer Ingelheim
10.1.1. Company Overview
10.1.2. Financial Performance
10.1.3. Product Benchmarking
10.1.4. Strategic Initiative
10.2. Pfizer
10.3. Novartis
10.4. Roche
10.5. AstraZeneca
10.6. Piramal
10.7. Abbott
10.8. Hospira
10.9. Baxter
10.10. AbbVie
10.11. Aspen
10.12. B. Braun
10.13. Fresenius Kabi
10.14. Hikma Pharmaceuticals PLC
10.15. Mylan N.V.
Chapter 11 Market Estimates and Forecast
11.1 Market Estimates and Forecast 2018-2024(USD Million)
11.1.1 Market Estimation and Forecast by Type 2018-2024 (USD Million)
11.1.2 Market Estimation and Forecast by Routes of Administration 2018-2024 (USD Million)
11.1.3 Market Estimates and Forecast by Geography 2018-2024 (USD Million)
Chapter 12 Market Insights
12.1 Insights of Industry Experts
12.2 Analyst Opinion (Market Understanding)
12.3 Investment Opportunities
Chapter 13 Appendix
13.1 List of Tables
13.2 List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Our Clientele
Exclusive Benefits
Credibility and Transparency
We actively recruit consumers, business professionals, and hard-to-reach individuals as members of our research panels, and we build trusted, ongoing relationships with them. Thus we provide the complete list of primary and secondary data sources in the report to maintain the transparency and to assure the credibility.
Exhaustive Coverage
Detailed and extensive coverage in the geography.Survey consultation for brand tracking, concept testing, consumer behaviour, and more, we have you covered with market research services that scale to meet your needs.
Competitive Edge
Our reports cover most recent updates in the market till the date of the purchase. We identify, gather and timely deliver analysis on impact of unprecedented decisions of CXOs in COVID-19 catastrophe on many businesses, their clients and their clients' clients without additional cost.
Golden Opportunities
A comprehensive strategic sieve analysis of the market by our analysts and consultants, aided by AI tools helps us find the non-obvious, golden and emerging opportunities for you to evaluate.
Top-notch Reports Guaranteed
70% of our research is exclusive; no other research firm has the depth and breadth of our research.
Post Purchase Support
Post-purchase support is provided for all our reports, for three months from the date of purchase, where related queries will be answered within 24 business hours over telephone or email.